大葉大學圖書館 |

Real world drug discovery[electronic resource] :a chemist's guide to biotech and pharmaceutical research /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	615.19
書名/作者:	Real world drug discovery : a chemist's guide to biotech and pharmaceutical research // Robert M. Rydzewski.
作者:	Rydzewski, Robert M.
出版者:	Amsterdam ; : Elsevier,, 2008.
面頁冊數:	xvii, 515 p. : : ill. (some col.) ;; 26 cm.
標題:	Drug development.
標題:	Drug development - Methodology.
標題:	Pharmaceutical technology.
標題:	Drug Design.
標題:	Drug Evaluation.
標題:	Pharmacy.
標題:	Research.
ISBN:	9780080466170
ISBN:	0080466176
書目註:	Includes bibliographical references and index.
內容註:	1 The Drug Discovery Business to Date -- 2 The Drug Discovery Business to Come -- 3 Industrial Considerations -- 4 How Things Get Done: The Project Team -- 5 Project Considerations -- 6 Hit Generation -- 7 Turning Hits into Drugs -- 8 Initial Properties -- 9 ADME and PK Properties -- 10 Toxicity-Related Properties -- 11 A Career in Drug Discovery.
摘要、提要註:	Drug discovery increasingly requires a common understanding by researchers of the many and diverse factors that go into the making of new medicines. The scientist entering the field will immediately face important issues for which his education may not have prepared him: project teams, patent law, consultants, target product profiles, industry trends, Gantt charts, target validation, pharmacokinetics, proteomics, phenotype assays, biomarkers, and many other unfamiliar topics for which a basic understanding must somehow be obtained. Even the more experienced scientist can find it frustratingly difficult to get an overview of the many factors involved in modern drug discovery and often only after years of exploring does a whole and integrated picture emerge in the mind of the researcher. Real World Drug Discovery: A Chemist's Guide to Biotech and Pharmaceutical Research presents this kind of map of the landscape of drug discovery. In a single, readable volume it outlines processes and explains essential concepts and terms for the recent science graduate wondering what to expect in pharma or biotech, the medicinal chemist seeking a broader and more timely understanding of the industry, or the contractor or collaborator whose understanding of the commercial drug discovery process could increase the value of his contribution to it. Key Features: - Interviews with well-known experts in many of the fields involved, giving insightful comments from authorities on many of the sub-disciplines important to cutting edge drug discovery. - Helpful suggestions gleaned from years of experience in biotech and pharma, which represents a repository drug discovery "lore" not previously available in any book. - "Periodic Table of Drugs" listing current top-selling drugs arranged by target and laid out so that structural similarities and differences are plain and clear, with regular updates available at the book's website. - Extensive use of diagrams to illustrate concepts like biotech startup models, preteomic profiling for target identification, Gantt charts for project planning, etc.
電子資源:	An electronic book accessible through the World Wide Web; click for information

Real world drug discovery[electronic resource] :a chemist's guide to biotech and pharmaceutical research /
Rydzewski, Robert M.

Real world drug discoverya chemist's guide to biotech and pharmaceutical research /[electronic resource] :Robert M. Rydzewski. - 1st ed. - Amsterdam ;Elsevier,2008. - xvii, 515 p. :ill. (some col.) ;26 cm.

Includes bibliographical references and index.

1 The Drug Discovery Business to Date -- 2 The Drug Discovery Business to Come -- 3 Industrial Considerations -- 4 How Things Get Done: The Project Team -- 5 Project Considerations -- 6 Hit Generation -- 7 Turning Hits into Drugs -- 8 Initial Properties -- 9 ADME and PK Properties -- 10 Toxicity-Related Properties -- 11 A Career in Drug Discovery.

Drug discovery increasingly requires a common understanding by researchers of the many and diverse factors that go into the making of new medicines. The scientist entering the field will immediately face important issues for which his education may not have prepared him: project teams, patent law, consultants, target product profiles, industry trends, Gantt charts, target validation, pharmacokinetics, proteomics, phenotype assays, biomarkers, and many other unfamiliar topics for which a basic understanding must somehow be obtained. Even the more experienced scientist can find it frustratingly difficult to get an overview of the many factors involved in modern drug discovery and often only after years of exploring does a whole and integrated picture emerge in the mind of the researcher. Real World Drug Discovery: A Chemist's Guide to Biotech and Pharmaceutical Research presents this kind of map of the landscape of drug discovery. In a single, readable volume it outlines processes and explains essential concepts and terms for the recent science graduate wondering what to expect in pharma or biotech, the medicinal chemist seeking a broader and more timely understanding of the industry, or the contractor or collaborator whose understanding of the commercial drug discovery process could increase the value of his contribution to it. Key Features: - Interviews with well-known experts in many of the fields involved, giving insightful comments from authorities on many of the sub-disciplines important to cutting edge drug discovery. - Helpful suggestions gleaned from years of experience in biotech and pharma, which represents a repository drug discovery "lore" not previously available in any book. - "Periodic Table of Drugs" listing current top-selling drugs arranged by target and laid out so that structural similarities and differences are plain and clear, with regular updates available at the book's website. - Extensive use of diagrams to illustrate concepts like biotech startup models, preteomic profiling for target identification, Gantt charts for project planning, etc.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2009.

Mode of access: World Wide Web.

ISBN: 9780080466170

Source: 140428:140566Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

339189
Drug development.
Index Terms--Genre/Form:

336502
Electronic books.

LC Class. No.: RM301.25 / .R93 2008

Dewey Class. No.: 615.19

National Library of Medicine Call No.: QV 744 R992 2008

Real world drug discovery[electronic resource] :a chemist's guide to biotech and pharmaceutical research /
LDR:04292cam 2200361Ia 4500 001 346890
003 OCoLC
005 20110614113918.0
006 m d
007 cr cn|||||||||
008 111130s2008 ne a ob 001 0 eng d
020 $a 9780080466170
020 $a 0080466176
029 1 $a HEBIS $b 246721502
035 $a (OCoLC)413003361
035 $a ocn413003361
037 $a 140428:140566 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS
049 $a TEFA
050 1 4 $a RM301.25 $b .R93 2008
060 1 4 $a QV 744 R992 2008
082 0 4 $a 615.19 $2 22
100 1 $a Rydzewski, Robert M. $3 428146
245 1 0 $a Real world drug discovery $h [electronic resource] : $b a chemist's guide to biotech and pharmaceutical research / $c Robert M. Rydzewski.
250 $a 1st ed.
260 $a Amsterdam ; $a Boston : $b Elsevier, $c 2008.
300 $a xvii, 515 p. : $b ill. (some col.) ; $c 26 cm.
504 $a Includes bibliographical references and index.
505 0 $a 1 The Drug Discovery Business to Date -- 2 The Drug Discovery Business to Come -- 3 Industrial Considerations -- 4 How Things Get Done: The Project Team -- 5 Project Considerations -- 6 Hit Generation -- 7 Turning Hits into Drugs -- 8 Initial Properties -- 9 ADME and PK Properties -- 10 Toxicity-Related Properties -- 11 A Career in Drug Discovery.
505 0 $a The drug discovery business to date -- The drug discovery business to come -- Industrial considerations -- how things get done : the project team -- Project considerations -- Hit generation -- Turning hits into drugs -- Initial properties -- ADME and PK properties -- Toxicity related properties -- A career in drug discovery research.
520 $a Drug discovery increasingly requires a common understanding by researchers of the many and diverse factors that go into the making of new medicines. The scientist entering the field will immediately face important issues for which his education may not have prepared him: project teams, patent law, consultants, target product profiles, industry trends, Gantt charts, target validation, pharmacokinetics, proteomics, phenotype assays, biomarkers, and many other unfamiliar topics for which a basic understanding must somehow be obtained. Even the more experienced scientist can find it frustratingly difficult to get an overview of the many factors involved in modern drug discovery and often only after years of exploring does a whole and integrated picture emerge in the mind of the researcher. Real World Drug Discovery: A Chemist's Guide to Biotech and Pharmaceutical Research presents this kind of map of the landscape of drug discovery. In a single, readable volume it outlines processes and explains essential concepts and terms for the recent science graduate wondering what to expect in pharma or biotech, the medicinal chemist seeking a broader and more timely understanding of the industry, or the contractor or collaborator whose understanding of the commercial drug discovery process could increase the value of his contribution to it. Key Features: - Interviews with well-known experts in many of the fields involved, giving insightful comments from authorities on many of the sub-disciplines important to cutting edge drug discovery. - Helpful suggestions gleaned from years of experience in biotech and pharma, which represents a repository drug discovery "lore" not previously available in any book. - "Periodic Table of Drugs" listing current top-selling drugs arranged by target and laid out so that structural similarities and differences are plain and clear, with regular updates available at the book's website. - Extensive use of diagrams to illustrate concepts like biotech startup models, preteomic profiling for target identification, Gantt charts for project planning, etc.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2009. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on June 24, 2009). $n Access may be restricted to users at subscribing institutions.
650 0 $a Drug development. $3 339189
650 0 $a Drug development $x Methodology. $3 428147
650 0 $a Pharmaceutical technology. $3 218539
650 2 $a Drug Design. $3 402272
650 2 $a Drug Evaluation. $3 428148
650 2 $a Pharmacy. $3 343916
650 2 $a Research. $3 378184
655 7 $a Electronic books. $2 local $3 336502
710 2 $a ScienceDirect (Online service) $3 365609
776 1 $c Original $z 9780080466170 $z 0080466176 $w (OCoLC)261924442
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780080466170 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF